News
![smutek obezita muž bezradnost nadváha](https://www.prolekare.cz/media/cache/resolve/article_list_item_large/media/image/db400d325db0406ed3ee7617ab00024a.jpg)
Prevalence and Clinical Impact of Overweight and Obesity in the Hemophilia Population
Obesity is classified as a lifestyle disease with increasing prevalence and a rising contribution to morbidity and mortality in the general population. The epidemic of overweight and obesity also does not spare individuals with hemophilia. According to epidemiological data, the prevalence of obesity is also increasing in this population, causing a number of complications in many health aspects.
![IBD](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/fcbf3e5035b5ac500226d4a112a37380.png)
Tofacitinib Helps Restore Intestinal Epithelial Barrier
The Janus kinase inhibitor (JAKi) tofacitinib was relatively recently approved for the treatment of…
![aktivní psoriatickou artritidou](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/3c75c07f2871d0d413df32ec62f72fc1.png)
Safety and Efficacy of Long-term Tofacitinib Therapy in Patients with Active Psoriatic Arthritis – Interim Results of the OPAL Balance Study
Tofacitinib is a potent selective inhibitor of the Janus kinase (JAK) family indicated for the…
![cardiovascular disease arthritis](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/ff133402ef3bc5518c3eb7f1e6707981.png)
Cardiovascular Safety of Tofacitinib in Real-World Clinical Practice – Results of the STAR-RA Study
Recent results from the ORAL Surveillance clinical trial have raised concerns about the…
![ULCEROZNI](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/87204a46499ed8ce7d2bfc7d234271f9.png)
Maintenance of Remission with Tofacitinib in Patients with UC – Results of the OCTAVE Open Study
Tofacitinib is indicated for the treatment of ulcerative colitis (UC) in cases where conventional…
![žena_dítě_příroda](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/0e18c13dac0c8ce307b22298346cc50e.jpg)
Indication of Bilastine in Specific Patient Groups − Practical Tips for Clinical Practice
Bilastine is a non-sedating H1-antihistamine, which is very well tolerated by patients. It can be…
![žena_alergie_rýma_jaro](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/ce9e5143dc6fcf8e99bdc31af2ea1986.jpg)
Bilastine in the treatment of allergic rhinitis – meta-analysis shows advantage of lower somnolence
A newly published systematic review and meta-analysis evaluate the efficacy and safety of bilastine…
![CHOPN_starý muž](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/8b0a28867086b1851b272b0d76dd305d.jpg)
Need for Early Intervention in COPD − A Suitable Time for Mucolytic Treatment
Chronic Obstructive Pulmonary Disease (COPD) ranks third among the leading causes of morbidity and…
![Výzkum_grafy](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/955a00a686f7c8284825e5e66f16fff0.jpg)
What Did 3 Years of Data from the Czech National COPD Database Reveal?
In December of last year, the Czech multicenter research database on COPD was completed. This was…
![preskribce léků](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/2fbc9e4eb002f0c484abddc39b1869e5.jpg)
COPD is Treated Differently Across Europe – What Could Be the Reasons for This Variability?
As part of this year's Hradec Pneumological Days (HPD 2022), the head of the Pulmonary Clinic at…